Condensed Financial Information of the Parent Company (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Condensed Financial Information Disclosure [Abstract] |
|
| Schedule of Balance Sheets |
Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
ASSETS |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
23,908 |
|
|
$ |
16,527 |
|
|
Restricted cash |
|
|
662,894 |
|
|
|
— |
|
|
Short-term investments |
|
|
55,270 |
|
|
|
80,732 |
|
|
Prepaid expenses and other receivables |
|
|
377 |
|
|
|
485 |
|
|
Amount due from subsidiaries |
|
|
20,401 |
|
|
|
19,350 |
|
|
Dividends receivable |
|
|
3,616 |
|
|
|
3,517 |
|
|
Total current assets |
|
|
766,466 |
|
|
|
120,611 |
|
|
Investment in subsidiaries |
|
|
4,335,737 |
|
|
|
8,145,953 |
|
|
Total assets |
|
$ |
5,102,203 |
|
|
$ |
8,266,564 |
|
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
Accrued expenses and other payables |
|
$ |
5,404 |
|
|
$ |
4,306 |
|
|
Dividend payable |
|
|
657,856 |
|
|
|
— |
|
|
Total current liabilities |
|
|
663,260 |
|
|
|
4,306 |
|
|
Total liabilities |
|
$ |
663,260 |
|
|
$ |
4,306 |
|
|
EQUITY |
|
|
|
|
|
|
|
Common stock |
|
|
72 |
|
|
|
72 |
|
|
Additional paid-in capital |
|
|
550,168 |
|
|
|
550,168 |
|
|
Accumulated other comprehensive loss |
|
|
(513,252 |
) |
|
|
(707,806 |
) |
|
Retained earnings |
|
|
4,401,955 |
|
|
|
8,419,824 |
|
|
Total Sinovac shareholders' equity |
|
|
4,438,943 |
|
|
|
8,262,258 |
|
|
Total liabilities and equity |
|
$ |
5,102,203 |
|
|
$ |
8,266,564 |
|
|
| Schedule of Statements of Operations and Comprehensive Income (Loss) |
Statements of Operations and Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
Selling, general and administrative expenses |
|
$ |
42,770 |
|
|
$ |
17,535 |
|
|
$ |
11,418 |
|
|
Total operating expenses |
|
|
42,770 |
|
|
|
17,535 |
|
|
|
11,418 |
|
|
Loss from operations |
|
|
(42,770 |
) |
|
|
(17,535 |
) |
|
|
(11,418 |
) |
|
Other income |
|
|
3,754 |
|
|
|
5,944 |
|
|
|
3,133 |
|
|
Interest income |
|
|
25,917 |
|
|
|
381 |
|
|
|
622 |
|
|
Equity (losses) earnings of subsidiaries, net of tax |
|
|
(46,581 |
) |
|
|
102,115 |
|
|
|
(5,828 |
) |
|
Net (loss) income |
|
|
(59,680 |
) |
|
|
90,905 |
|
|
|
(13,491 |
) |
|
Other comprehensive income (loss), net of tax of nil |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
187,825 |
|
|
|
(133,769 |
) |
|
|
(170,931 |
) |
|
Unrealized gain (loss) on available-for-sales investments |
|
|
6,729 |
|
|
|
(10,619 |
) |
|
|
8,779 |
|
|
Total comprehensive income (loss) |
|
$ |
134,874 |
|
|
$ |
(53,483 |
) |
|
$ |
(175,643 |
) |
|
| Schedule of Statements of Cash Flows |
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
Operating activities |
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(59,680 |
) |
|
$ |
90,905 |
|
|
$ |
(13,491 |
) |
|
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
- Investment and interest income |
|
|
2,483 |
|
|
|
— |
|
|
|
— |
|
|
- Equity losses (earnings) of subsidiaries, net of tax |
|
|
46,581 |
|
|
|
(102,115 |
) |
|
|
5,828 |
|
|
Changes in: |
|
|
|
|
|
|
|
|
|
|
- Amount due from subsidiaries |
|
|
(1,051 |
) |
|
|
3,303 |
|
|
|
8,366 |
|
|
- Prepaid expenses and other receivables |
|
|
108 |
|
|
|
(309 |
) |
|
|
314 |
|
|
- Dividend receivable |
|
|
(99 |
) |
|
|
(322 |
) |
|
|
— |
|
|
- Amount due to subsidiaries |
|
|
— |
|
|
|
(4,448 |
) |
|
|
454 |
|
|
- Accrued expenses and other payables |
|
|
1,098 |
|
|
|
2,058 |
|
|
|
1,116 |
|
|
Net cash (used in) provided by operating activities |
|
|
(10,560 |
) |
|
|
(10,928 |
) |
|
|
2,587 |
|
|
Investing activities |
|
|
|
|
|
|
|
|
|
|
- Distribution from a subsidiary |
|
|
3,958,189 |
|
|
|
— |
|
|
|
— |
|
|
- Proceeds from maturity and sales of investments |
|
|
107,979 |
|
|
|
93,418 |
|
|
|
49,850 |
|
|
- Purchase of investments |
|
|
(85,000 |
) |
|
|
(76,000 |
) |
|
|
(148,000 |
) |
|
Net cash provided by (used in) investing activities |
|
|
3,981,168 |
|
|
|
17,418 |
|
|
|
(98,150 |
) |
|
Financing activities |
|
|
|
|
|
|
|
|
|
|
- Proceeds from exercised stock options |
|
|
— |
|
|
|
— |
|
|
|
676 |
|
|
- Cash paid for dividends |
|
|
(3,300,333 |
) |
|
|
— |
|
|
|
— |
|
|
Net cash (used in) provided by financing activities |
|
|
(3,300,333 |
) |
|
|
— |
|
|
|
676 |
|
|
Increase (decrease) in cash and cash equivalents |
|
|
670,275 |
|
|
|
6,490 |
|
|
|
(94,887 |
) |
|
Cash and cash equivalents and restricted cash, beginning of year |
|
|
16,527 |
|
|
|
10,037 |
|
|
|
104,924 |
|
|
Cash and cash equivalents and restricted cash, end of year |
|
$ |
686,802 |
|
|
$ |
16,527 |
|
|
$ |
10,037 |
|
|